- Home
- TALKW vs SNN Comparison
TALKW vs SNN Comparison
Compare TALKW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALKW
- SNN
- Stock Information
- Founded
- TALKW 2012
- SNN 1856
- Country
- TALKW United States
- SNN United Kingdom
- Employees
- TALKW 521
- SNN N/A
- Industry
- TALKW Medical/Nursing Services
- SNN Industrial Specialties
- Sector
- TALKW Health Care
- SNN Health Care
- Exchange
- TALKW Nasdaq
- SNN Nasdaq
- Market Cap
- TALKW N/A
- SNN 12.6B
- IPO Year
- TALKW N/A
- SNN 1999
- Fundamental
- Price
- TALKW N/A
- SNN $30.28
- Analyst Decision
- TALKW
- SNN Hold
- Analyst Count
- TALKW 0
- SNN 3
- Target Price
- TALKW N/A
- SNN $27.50
- AVG Volume (30 Days)
- TALKW 64.2K
- SNN 915.5K
- Earning Date
- TALKW 02-20-2025
- SNN 07-31-2025
- Dividend Yield
- TALKW N/A
- SNN 2.38%
- EPS Growth
- TALKW N/A
- SNN 56.15
- EPS
- TALKW N/A
- SNN 0.47
- Revenue
- TALKW $181,291,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- TALKW N/A
- SNN $6.87
- Revenue Next Year
- TALKW N/A
- SNN $5.19
- P/E Ratio
- TALKW N/A
- SNN $32.11
- Revenue Growth
- TALKW 31.50
- SNN 4.70
- 52 Week Low
- TALKW $0.20
- SNN $23.69
- 52 Week High
- TALKW $0.24
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- TALKW N/A
- SNN 60.00
- Support Level
- TALKW N/A
- SNN $29.99
- Resistance Level
- TALKW N/A
- SNN $30.77
- Average True Range (ATR)
- TALKW 0.00
- SNN 0.40
- MACD
- TALKW 0.00
- SNN 0.04
- Stochastic Oscillator
- TALKW 0.00
- SNN 79.32
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.